ARROWHEAD PHARMACEUTICALS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Arrowhead Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$171M, a 65.9% decline year-over-year.
  • Arrowhead Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$539M, a 197% decline year-over-year.
  • Arrowhead Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$205M, a 16.6% decline from 2022.
  • Arrowhead Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$176M, a 25% decline from 2021.
  • Arrowhead Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$141M, a 66.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$539M -$171M -$67.8M -65.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$471M -$125M -$174M -357% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$297M -$133M -$91.5M -222% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-06
Q3 2023 -$205M -$110M -$24.2M -28.3% Jul 1, 2023 Sep 30, 2023 10-K 2023-11-29
Q2 2023 -$181M -$103M -$30.9M -42.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$150M $48.7M +$4.31M +9.71% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$155M -$41.3M +$21.5M +34.3% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-06
Q3 2022 -$176M -$85.5M -$22.1M -34.9% Jul 1, 2022 Sep 30, 2022 10-K 2023-11-29
Q2 2022 -$154M -$72M -$42.1M -141% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$112M $44.4M +$71.2M Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-07
Q4 2021 -$183M -$62.9M -$42.1M -203% Oct 1, 2021 Dec 31, 2021 10-Q 2023-08-07
Q3 2021 -$141M -$63.4M -$14.9M -30.8% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-29
Q2 2021 -$126M -$29.9M -$16.3M -120% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$110M -$26.8M -$6.98M -35.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$103M -$20.7M -$18.1M -676% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-02
Q3 2020 -$84.6M -$48.4M -$60.1M -514% Jul 1, 2020 Sep 30, 2020 10-K 2022-11-28
Q2 2020 -$24.4M -$13.6M -$33.9M -167% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $9.53M -$19.8M -$43.7M -183% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $53.3M -$2.67M -$14.7M -122% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $68M $11.7M +$22.5M Jul 1, 2019 Sep 30, 2019 10-K 2021-11-22
Q2 2019 $45.5M $20.3M +$35.9M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $9.57M $23.9M +$38.8M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$29.2M $12M +$25.2M Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-05
Q3 2018 -$54.5M -$10.8M -$29.4K -0.27% Jul 1, 2018 Sep 30, 2018 10-K 2020-11-23
Q2 2018 -$54.4M -$15.6M -$10.1M -183% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 -$44.3M -$14.9M -$8.84M -146% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$35.5M -$13.2M -$1.11M -9.21% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 -$34.4M -$10.7M +$11.5M +51.7% Jul 1, 2017 Sep 30, 2017 10-K 2017-12-12
Q2 2017 -$45.9M -$5.52M +$13.9M +71.6% Apr 1, 2017 Jun 30, 2017 10-K 2017-12-12
Q1 2017 -$59.8M -$6.04M +$14.8M +71% Jan 1, 2017 Mar 31, 2017 10-K 2017-12-12
Q4 2016 -$74.5M -$12.1M +$7.18M +37.3% Oct 1, 2016 Dec 31, 2016 10-K 2017-12-12
Q3 2016 -$81.7M -$22.2M +$2.52M +10.2% Jul 1, 2016 Sep 30, 2016 10-K 2017-12-12
Q2 2016 -$84.2M -$19.4M -$3.48M -21.9% Apr 1, 2016 Jun 30, 2016 10-K 2017-12-12
Q1 2016 -$80.8M -$20.8M +$7.87M +27.4% Jan 1, 2016 Mar 31, 2016 10-K 2017-12-12
Q4 2015 -$88.6M -$19.3M +$3.31M +14.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-12-12
Q3 2015 -$91.9M -$24.7M -$2.31M -10.3% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-14
Q2 2015 -$89.6M -$15.9M -$4.31M -37.1% Apr 1, 2015 Jun 30, 2015 10-K 2016-12-14
Q1 2015 -$85.3M -$28.7M -$14.7M -106% Jan 1, 2015 Mar 31, 2015 10-K 2016-12-14
Q4 2014 -$70.6M -$22.6M -$11.9M -112% Oct 1, 2014 Dec 31, 2014 10-K 2016-12-14
Q3 2014 -$58.6M -$22.4M -$8.74M -63.8% Jul 1, 2014 Sep 30, 2014 10-K 2015-12-14
Q2 2014 -$49.9M -$11.6M -$5.55M -91.3% Apr 1, 2014 Jun 30, 2014 10-K 2015-12-14
Q1 2014 -$44.3M -$13.9M -$7.18M -106% Jan 1, 2014 Mar 31, 2014 10-K 2015-12-14
Q4 2013 -$37.2M -$10.6M -$6.01M -130% Oct 1, 2013 Dec 31, 2013 10-K 2015-12-14
Q3 2013 -$31.1M -$13.7M -$8.38M -158% Jul 1, 2013 Sep 30, 2013 10-K 2014-11-25
Q2 2013 -$22.8M -$6.08M +$1.91M +23.9% Apr 1, 2013 Jun 30, 2013 10-K 2014-11-25
Q1 2013 -$24.7M -$6.76M -$1.42M -26.7% Jan 1, 2013 Mar 31, 2013 10-K 2014-11-25
Q4 2012 -$23.3M -$4.61M -$2.13M -85.6% Oct 1, 2012 Dec 31, 2012 10-K 2014-11-25
Q3 2012 -$21.1M -$5.31M -$2.54M -91.4% Jul 1, 2012 Sep 30, 2012 10-K 2014-11-25
Q2 2012 -$18.6M -$7.99M -$6.17M -339% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 -$12.4M -$5.34M -$8.24M -284% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$4.18M -$2.49M -$1.05M -72.9% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-13
Q3 2011 -$3.13M -$2.78M Jul 1, 2011 Sep 30, 2011 10-K 2012-12-28
Q2 2011 -$1.82M -$1.45M -390% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 $2.91M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 -$1.44M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-09
Q2 2010 -$371K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.